PWPS
RCUS icon

Pinnacle Wealth Planning Services’s Arcus Biosciences RCUS Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.6K Buy
2,666
+103
+4% +$2.22K 0.01% 1119
2025
Q4 		$61.1K Buy
+2,563
New +$52.3K 0.01% 1064
2021
Q1 		– Sell
-1,165
Closed -$30K – 1580
2020
Q4 		$30K Buy
+1,165
New +$28.2K 0.01% 1003

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Pinnacle Wealth Planning Services's RCUS Position: Q1 2026 in Review

Pinnacle Wealth Planning Services increased its Arcus Biosciences (RCUS) stake by 4% in Q1 2026, buying an estimated $2.22K and bringing the position to 2,666 shares worth $57.6K. The position accounts for 0.01% of the portfolio, ranked #1119.

Pinnacle Wealth Planning Services first reported a position in RCUS in Q4 2020 and has held it in 3 quarters since. The position peaked at $61.1K in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Pinnacle Wealth Planning Services held 2,666 shares of Arcus Biosciences worth $57.6K as of Q1 2026.
  • Pinnacle Wealth Planning Services bought 103 Arcus Biosciences shares in Q1 2026, an estimated $2.22K.
  • Arcus Biosciences made up 0.01% of Pinnacle Wealth Planning Services's portfolio in Q1 2026, its #1119 holding.
  • Pinnacle Wealth Planning Services first reported a position in Arcus Biosciences in Q4 2020 and has held it in 3 quarters since.
  • Pinnacle Wealth Planning Services's Arcus Biosciences position peaked at $61.1K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2026, filed 11 May 2026.